Allied Market Research
image  Direct : +1 (617) 674-4143 | Toll Free : +1 (855) 711-1555


Report Image
Flow Cytometry Market (Products, Application, Technology, and Users) - Current Trends, Opportunities, Industry Analysis, Size, Share and Global Forecast, 2012-2020
Published: Dec-2013    |    Formats: PDF & Excel   |   Author(s):Debbie Shields and Rohini Patil   |   Code: DI 1390
  • Report
    Overview
  • Table of
    Contents
  • Research
    Methodology
  • Analyst's
    Review
  • Sample

Pages 135
Tables 72

Flow cytometry measures and analyzes cells of various characterizations through a light beam that is passed through a suspension of fluid. Several properties of the cell structure and functions can be studied with the help of this technique. Flow cytometry market was valued $3000 million in 2012, and is expected to reach a value of $6530 million by 2020, experiencing a CAGR of 30.9%. The factor driving this market is the increase in scope of application areas such as drug discovery, stem cell sorting, marine biology, etc. The major limitation of this market is the cost of the instrument due to the need for high investment for production and maintenance. Flow cytometry finds its opportunities in the clinical and research approaches.

The key market players profiled in this report are BD Biosciences, Beckman Coulter, Merck Millipore, Amnis Corporation, Life Technologies Corporation, Luminex Corporation, Morphosys AG, eBiosciences Inc., Partec Gmbh and Advanced Analytical Technologies, Inc.

Fow cytometry market ready to take cell application to a new tangent

KEY BENEFITS

  • The report ranks the factors that are responsible to accelerate the market growth of flow cytometry
  • Market is forecasted for period of seven years from 2013 to 2020, with market revenues for 2 historic years  - 2011 and 2012
  • Identification and analysis of key investment pockets for flow cytometry market players
  • Identification of challenges that must be addressed and overcome in the flow cytometry market to achieve fiscal success throughout the market
  • The report identifies and profiles key market participants that would drive innovation in the flow cytometry market  

KEY MARKET SEGMENTS
GLOBAL MARKET, BY PRODUCT

  • FC instruments
  • Reagents
  • Consumables
  • Software
  • Services
  • Accessories

GLOBAL MARKET, BY TECHNOLOGY

  • Cell based Technologies
  • Bead-based Technologies

GLOBAL MARKET, BY APPLICATION

  • Clinical
    • Apoptosis
    • Cell Cycle Analysis
    • Cell sorting
    • Cell Viability
  • Research Fields
    • Organ transplantation
    • Cancer
    • Immunodeficiency Disease
    • Hematology Haematological Malignancies

GLOBAL MARKET, BY END USERS

  • Commercial Organizations
  • Hospitals
  • Academic Institutes
  • Medical Schools
  • Clinical Testing Labs
  • Others

GLOBAL MARKET, BY GEOGRAPHY

  • North America
  • Europe
  • Asia Pacific
  • RoW

KEY AUDIENCES

  • Clinical institutes
  • Research institutes
  • Pharma and biotech companies
  • Academic institutes

CHAPTER 1 INTRODUCTION

1.1 Objective and Scope of the Report
1.2 Key Deliverables of the Report
1.3 Unique Benefits of the Report
1.4 Key Audiences
1.5 Research Methodology

1.5.1 Secondary research
1.5.2 Primary research
1.5.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 GLOBAL FLOW CYTOMETRY MARKET OVERVIEW

3.1 Market Definition and Scope

3.1.1 Key applications of Flow cytometry
3.1.2 Application of Flow Cytometry in Gender Selection
3.1.3 Flow cytometry in Omics Technology

3.1.3.1 Applications of omics technology

3.1.3.1.1 Lung disease identification
3.1.3.1.2 Quantifying Abnormalities
3.1.3.1.3 Genetic Trait Diagnosis
3.1.3.1.4 Pharmacogenomics

3.1.4 Flow Cytometry in Immunophenotyping

3.1.4.1 Immunophenotyping in hematology applications

3.1.4.1.1 Erythrocyte analysis
3.1.4.1.2 Leukocyte Analysis
3.1.4.1.3 Platelet analysis

3.1.5 Flow cytometry in blood bank

3.1.6 Optimization of Flow Cytometry by Information Technology
3.1.7 Use Of Flow Cytometry In Resource-Poor Regions

 3.2 Top factors impacting Flow cytometry Market
 3.3 Top three winning strategies in the flow cytometry market

3.3.1 Product Launch
3.3.2 Agreement and Collaboration
3.3.3 Acquisition

3.4 Top investment pockets in flow cytometry market

3.4.1 Flow cytometry market- by clinical application
3.4.2 Flow cytometry market- by Research application
3.4.3 Flow cytometry market- by End users

3.5 Porter’s Five Forces Analysis

3.5.1 Intense Competition DecliningSupplier’s Power
3.5.2 Wide Range of Product Availability Enhances Buyer’s Power
3.5.3 Strategies to Be in Place to Combat Competition
3.5.4 High Investment Restricting Low Investment New Comers
3.5.5 Pricing Issues Impacting Adoption Rates

3.6 Reimbursement Scenario
3.7 Regulatory Issues

3.7.1 Challenges- in FDA Clearance
3.7.2 Impact of ASR Rule
3.7.3 Validation Challenges- Cell-Based
3.7.4 Validation Requirements (CLIA, CAP)
3.7.5 LDT Guidelines on Cell-based Fluorescence
3.7.6 Change in Regulations

3.8 Case studies

3.8.1 Case study 1: Expansion of the number of antibody conjugates
3.8.2 Case study 2: Recognition of target antibodies conjugates, Anti-human CD3: FITC.
3.8.3 Case study 3: To prove precursor B acute lymphoblastic leukemia has unusual transformation
3.8.4 Case study 4: To develop software that can run faster than the current flow cytometer software
3.8.5 Case study 5: To validate the mechanism of a candidate biologic drug

3.9 Market Dynamics

3.9.1 Drivers

3.9.1.1  Technological advancements
3.9.1.2 Clinical and research fields
3.9.1.3 Increase in scope of Applications areas
3.9.1.4 Investment in R&D
3.9.1.5 Increase in number of patients

3.9.2 RESTRAINTS

3.9.2.1 Instrument costs
3.9.2.2 Need of awareness
3.9.2.3 Need of trained personnel

3.9.3 OPPORTUNITIES 

3.9.3.1 In clinical approach
3.9.3.2 Research approach

CHAPTER 4 FLOW CYTOMETRY MARKET BY PRODUCT

4.1 Global flow cytometry market, by product type, 2012-2020, $million

4.1.1 Global flow cytometry Product market, by geography, 2012-2020, $million

4.2 Instruments

4.2.1 Global flow cytometry Product market ,by instruments, 2012-2020,$million
4.2.2 Global flow cytometry-instruments market, by geography, 2012-2020, $million
4.2.3 Key Market Drivers

4.2.3.1 Popularity of bench top flow cytometers
4.2.3.2 Technological trends

4.2.4 Platforms

4.2.4.1 Types of platforms

4.2.4.1.1 Single-Platform Approach

4.2.4.1.1.1 TYPES OF SINGLE PLATFORM

4.2.4.2 Global flow cytometry Product market, by platform, 2012-2020,$million
4.2.4.3 Global flow cytometry platform market, by geography, 2012-2020, $million
4.2.4.4 Sorters

4.2.4.4.1 Types of Sorters

4.2.4.5 Analysers

4.2.5 Replaceable Components

4.2.5.1 Drivers of Replaceable Components Market
4.2.5.2 Global flow cytometry replaceable components market, by types, 2012-2020, $million
4.2.5.3 Global flow cytometry replaceable components market, by geography, 2012-2020, $million
4.2.5.4 Filters

4.2.5.4.1 Types of filters
4.2.5.4.2 Global flow cytometry filters market, by geography, 2012-2020, $million

4.2.5.5 Lasers

4.2.5.5.1 Global flow cytometry lasers market, by geography, 2012-2020, $million

4.2.5.6 Detectors

4.2.5.6.1 Global flow cytometry detectors market, by geography, 2012-2020, $million

4.2.5.7 Others

4.2.5.7.1 Global flow cytometry other components market, by geography, 2012-2020, $million

4.2.6 Accessories

4.2.6.1 Global flow cytometry Accessories market, by geography, 2012-2020, $million

4.3 Reagents and Consumables

4.3.1 Drivers of Reagents and consumables market
4.3.2 Global flow cytometry reagents and consumables market, by type, 2012-2020, $million
4.3.3 Global flow cytometry reagents and consumables market, by geography, 2012-2020, $million
4.3.4 Antibodies

4.3.4.1 Global flow cytometry antibodies market, by geography, 2012-2020, $million

4.3.5 Dyes

4.3.5.1 Global flow cytometry dyes market, by geography, 2012-2020, $million

4.3.6 Beads

4.3.6.1 Global flow cytometry beads market, by geography, 2012-2020, $million

4.3.7 Others

4.3.7.1 Reagent kits
4.3.7.2 Beads
4.3.7.3 Solutions
4.3.7.4 Buffers
4.3.7.5 Global flow cytometry other reagents and consumables market, by geography, 2012-2020, $million

4.4 Software

4.4.1 Global flow cytometry market, by software, 2012-2020, $million
4.4.2 Global flow cytometry- software market, by geography, 2012-2020, $million
4.4.3 With-System Software

4.4.3.1 Global flow cytometry with system market, by geography, 2012-2020, $million

4.4.4 Third Party Software

4.4.4.1 Global flow cytometry- third party market, by geography, 2012-2020, $million

4.5 Services

4.5.1 Global flow cytometry services market, by geography, 2012-2020, $million

CHAPTER 5 FLOW CYTOMETRY MARKET BY TECHNOLOGY

5.1 Global flow cytometry market, by technology, 2012-2020, $million
5.2 Global flow cytometry- technology market, by geography, 2012-2020, $million
5.3 Bead-Based Flow cytometry

5.3.1 Drivers of Bead Based Flow Cytometry Market

5.3.1.1 Application in the field of  genomics
5.3.1.2 Application in the field of proteomics
5.3.1.3 High competitive edge

5.3.2 Global flow cytometry bead based market, by geography, 2012-2020, $million

5.4 Cell Based Flow Cytometers

5.4.1 Global flow cytometry cell based market, by geography, 2012-2020, $million

CHAPTER 6 FLOW CYTOMETRY MARKET BY APPLICATION

6.1 Drivers of the Flow Cytometry Application Market

6.1.1 Research funds
6.1.2 Need for management in disease control
6.1.3 Increase in flow cytometry end users

6.2 Restraints of the flow cytometry application market
6.3 Global flow cytometry market, by applications, 2012-2020, $million
6.4 Global flow cytometry-application market , by geography, 2012-2020, $million
6.5 Research Applications

6.5.1 Global flow cytometry market, by research applications, 2012-2020, $million
6.5.2 Global flow cytometry-research application market, by geography, 2012-2020, $million
6.5.3 Cell Cycle Analysis and Cell Proliferation

6.5.3.1 Global flow cytometry Cell cycle analysis and Cell proliferation market, by geography, 2012-2020, $million

6.5.4 Apoptosis

6.5.4.1 Drivers of Apoptosis market
6.5.4.2 Global flow cytometry Apoptosis market, by geography, 2012-2020, $million

6.5.5 Cell Sorting

6.5.5.1  Global flow cytometry Cell sorting market, by geography, 2012-2020, $million

6.5.6 Transfection and Cell Viability

6.5.6.1 Global flow cytometry Transfection and Cell viability market, by geography, 2012-2020, $million

6.5.7 Others

6.5.7.1 Global flow cytometry other research application market, by geography, 2012-2020, $million

6.6 Clinical Applications

6.6.1 Global flow cytometry market, by clinical applications, 2012-2020, $million
6.6.2 Global flow cytometry clinical application market, by geography, 2012-2020, $million
6.6.3 Organ Transplantation

6.6.3.1 Drivers of Organ transplantation market
6.6.3.2 Global flow cytometry organ transplant market, by geography, 2012-2020, $million

6.6.4 Hematology Hematological Malignancies

6.6.4.1 Global flow cytometry Hematology hematological malignancies market, by geography, 2012-2020, $million
6.6.4.2 Myeloma
6.6.4.3 Lymphomas
6.6.4.4 Leukemia

6.6.5 Cancer and Solid Tumour

6.6.5.1 Drivers of Cancer and solid tumor market
6.6.5.2 Restraints of Cancer and solid tumor market
6.6.5.3 Global flow cytometry Cancer and solid tumor market, by geography, 2012-2020, $million

6.6.6 Immunodeficiency Disease-HIV Infection

6.6.6.1 Key facts about HIV
6.6.6.2 Drivers of HIV market
6.6.6.3 Restraints of HIV market
6.6.6.4 Global flow cytometry Immunodeficiency disease-HIV infectionmarket, by geography, 2012-2020, $million

6.6.7 Others

6.6.7.1 Global flow cytometry other clinical application market, by geography, 2012-2020, $million

CHAPTER 7 FLOW CYTOMETRY MARKET BY END USER

7.1 Global flow cytometry market, by end user, 2012-2020, $million
7.2 Global flow cytometry end user market, by geography, 2012-2020, $million
7.3 Commercial Organizations

7.3.1 Global flow cytometry commercial market, by geography, 2012-2020, $million

7.4 Medical Schools and Clinical Testing Labs

7.4.1 Global flow cytometry medical schools and clinical testing labs market, by geography, 2012-2020, $million

7.5 Hospitals

7.5.1 Global flow cytometry hospitals market, by geography, 2012-2020, $million

7.6 Academics

7.6.1 Global flow cytometry Academics market, by geography, 2012-2020, $million

7.7 Others

7.7.1 Global flow cytometry other end user market, by geography, 2012-2020, $million

CHAPTER 8 FLOW CYTOMETRY MARKET BY GEOGRAPHY

8.1 North America

8.1.1 Drivers of the North American Market
8.1.2 North American flow cytometry market, 2012-2020, $million

8.2 Europe

8.2.1 Drivers of the European market
8.2.2 European flow cytometry market, 2012-2020, $million

8.3 Asia Pacific and RoW

8.3.1 Asia and RoW flow cytometry market, 2012-2020, $million

CHAPTER 9 COMPANY PROFILES

9.1 Advanced Analytical Technologies, Inc (AATI)

9.1.1 Company Overview
9.1.2 Company Snapshot
9.1.3 Strategies and Development
9.1.4 Swot Analysis of Advanced Analytical Technologies

9.2 Merck Millipore

9.2.1 Company Overview
9.2.2 Company Snapshot
9.2.3 Business Performance
9.2.4 Strategies and Development

9.2.4.1 Primary strategies: Agreement
9.2.4.2 Other strategies

9.2.5 SwotAnalysis of Merck Millipore

9.3 Life Technologies Corporation

9.3.1 Company Overview
9.3.2 Company Snapshot
9.3.3 Business Performance
9.3.4 Strategies and Development

9.3.4.1 Primary Strategies: Agreement
9.3.4.2 Secondary Strategies: Launch and Acquisition

9.3.5 SwotAnalysis of Life Technologies Corporation.

9.4 Beckman Coulter, Inc.

9.4.1 Company overview
9.4.2 Company Snapshot
9.4.3 Strategies and Development

9.4.3.1 Primary strategies: product Launch
9.4.3.2 Secondary strategies: Agreement & acquisition

9.4.4 Swot Analysis OF Beckman Coulter, Inc.

9.5 Becton, Dickinson & Co.

9.5.1 Company Overview
9.5.2 Snapshot of Becton, Dickinson & CO.
9.5.3 Business Performance
9.5.4 Strategies and Development

9.5.4.1 Primary strategies: Launch
9.5.4.2 Other strategies

9.5.5 SWOT analysis of Becton, Dickinson & Co

9.6 Luminex Corporation

9.6.1 Company Overview
9.6.2 Snapshot
9.6.3 Business Performance
9.6.4 Strategies and Development

9.6.4.1 Primary strategies: Agreement
9.6.4.2 Other strategies

9.6.5 Swot Analysis of LUMINEX CORPORATION

9.7 AmnisCorporation

9.7.1 Company Overview
9.7.2 Snapshot
9.7.3 Strategies and Development

9.7.3.1 Primary strategies: Launch
9.7.3.2 Other strategies

9.7.4 SwotAnalysis of AmnisCorporation

9.8 Partec GmbH

9.8.1 Company Overview
9.8.2 Snapshot
9.8.3 Strategies and Development
9.8.4 SwotAnalysis of Partec GmbH

9.9 EBIOSCIENCE, Inc.

9.9.1 Company Overview
9.9.2 Snapshot
9.9.3 Business Performance
9.9.4 Strategies and Development

9.9.4.1 Primary strategies: launch
9.9.4.2 Other strategies

9.9.5 Swot Analysis of eBioscience, Inc.

9.10 MORPHOSYS AG

9.10.1 Company Overview
9.10.2 Snapshot
9.10.3 Business performance
9.10.4 Strategies and Development

9.10.4.1 Primary strategies: Agreement, Launch.
9.10.4.2 Other strategies

9.10.5 Swot Analysis of Morphosys AG

 

LIST OF TABLES:

TABLE 1 GLOBAL FLOW CYTOMETRY PRODUCT MARKET, BY GEOGRAPHY 2012-2020 ($MILLION)
TABLE 2 GLOBAL FLOW CYTOMETRY MARKET, BY PRODUCT TYPE, 2012-2020, $MILLION
TABLE 3 GLOBAL FLOW CYTOMETRY PRODUCT MARKET BY GEOGRAPHY 2012-2020 ($MILLION)
TABLE 4 GLOBAL FLOW CYTOMETRY PRODUCT MARKET BY, INSTRUMENTS, 2012-2020, $MILLION
TABLE 5 GLOBAL FLOW CYTOMETRY-INSTRUMENTS MARKET BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 6 TYPES OF PLATFORM
TABLE 7 GLOBAL FLOW CYTOMETRY PRODUCT MARKET, BY PLATFORMS, 2012-2020, MILLIONS
TABLE 8 GLOBAL FLOW CYTOMETRY PLATFORM MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 9 TYPES OF SORTERS:
TABLE 10 GLOBAL FLOW CYTOMETRY SORTERS MARKET, BY GEOGRAPHY 2012-2020 ($MILLION)
TABLE 11 ANALYZERS BY KEY PLAYERS
TABLE 12 GLOBAL FLOW CYTOMETRY ANALYSERS MARKET, BY GEOGRAPHY 2012-2020 ($MILLION)
TABLE 13 GLOBAL FLOW CYTOMETRY PRODUCT MARKET, BY REPLACEABLE COMPONENTS MARKET, 2012-2020, $MILLION
TABLE 14 GLOBAL FLOW CYTOMETRY REPLACEABLE COMPONENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 15 TYPES OF FILTERS
TABLE 16 GLOBAL FLOW CYTOMETRY FILTERS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 17 GLOBAL FLOW CYTOMETRY LASERS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 18 TYPES OF DETECTORS
TABLE 19 GLOBAL FLOW CYTOMETRY DETECTORS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 20 GLOBAL FLOW CYTOMETRY OTHER COMPONENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 21 GLOBAL FLOW CYTOMETRY ACCESSORIES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 22 GLOBAL FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY TYPE, 2012-2020, $MILLION
TABLE 23 GLOBAL FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 24 GLOBAL FLOW CYTOMETRY ANTIBODIES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 25 GLOBAL FLOW CYTOMETRY DYES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 26 GLOBAL FLOW CYTOMETRY BEADS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 27 GLOBAL FLOW CYTOMETRY OTHER REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 28 GLOBAL FLOW CYTOMETRY MARKET , BY SOFTWARE, 2012-2020, $MILLION
TABLE 29 GLOBAL FLOW CYTOMETRY- SOFTWARE MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 30 GLOBAL FLOW CYTOMETRY WITH SYSTEM MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 31 GLOBAL FLOW CYTOMETRY- THIRD PARTY MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 32 GLOBAL FLOW CYTOMETRY SERVICES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 33 GLOBAL FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2012-2020, $MILLION
TABLE 34 GLOBAL FLOW CYTOMETRY- TECHNOLOGY MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 35 GLOBAL FLOW CYTOMETRY BEAD BASED MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 36 GLOBAL FLOW CYTOMETRY CELL BASED MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 37 GLOBAL FLOW CYTOMETRY MARKET, BY APPLICATIONS, 2012-2020, $MILLION
TABLE 38 GLOBAL FLOW CYTOMETRY-APPLICATION MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 39 GLOBAL FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2012-2020, $MILLION
TABLE 40 GLOBAL FLOW CYTOMETRY-RESEARCH APPLICATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 41 GLOBAL FLOW CYTOMETRY CELL CYCLE ANALYSIS AND CELL PROLIFERATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 42 GLOBAL FLOW CYTOMETRY APOPTOSIS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 43 GLOBAL FLOW CYTOMETRY CELL SORTING MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 44 GLOBAL FLOW CYTOMETRY TRANSFECTION AND CELL VIABILITY MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 45 GLOBAL FLOW CYTOMETRY OTHER RESEARCH APPLICATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 46 GLOBAL FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2012-2020, $MILLION
TABLE 47 GLOBAL FLOW CYTOMETRY CLINICAL APPLICATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 48 GLOBAL FLOW CYTOMETRY ORGAN TRANSPLANT MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 49 GLOBAL FLOW CYTOMETRY HEMATOLOGY HEMATOLOGICAL MALIGNANCIES MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 50 GLOBAL FLOW CYTOMETRY CANCER AND SOLID TUMOR MARKET MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 51 GLOBAL FLOW CYTOMETRY IMMUNODEFICIENCY DISEASE-HIV INFECTION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 52 GLOBAL FLOW CYTOMETRY OTHER CLINICAL APPLICATION MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 53 GLOBAL FLOW CYTOMETRY MARKET, BY END USER, 2012-2020, $MILLION
TABLE 54 GLOBAL FLOW CYTOMETRY END USER MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 55 GLOBAL FLOW CYTOMETRY COMMERCIAL MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 56 GLOBAL FLOW CYTOMETRY MEDICAL SCHOOLS AND CLINICAL TESTING LABS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 57 GLOBAL FLOW CYTOMETRY HOSPITALS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 58 GLOBAL FLOW CYTOMETRY ACADEMICS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 59 GLOBAL FLOW CYTOMETRY OTHER END USER MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 60 NORTH AMERICAN FLOW CYTOMETRY MARKET, 2012-2020, $MILLION
TABLE 61 EUROPEAN FLOW CYTOMETRY MARKET,2012-2020, $MILLION
TABLE 62 ASIA AND ROW FLOW CYTOMETRY MARKET, 2012-2020, $MILLION
TABLE 63 SNAPSHOT OF ADVANCED ANALYTICAL TECHNOLOGIES, INC (AATI)
TABLE 64 SNAPSHOTOF MERCK MILLIPORE,
TABLE 65 SNAPSHOT OF LIFE TECHNOLOGIES CORPORATION
TABLE 66 SNAPSHOT OF BECKMAN COULTER, INC.
TABLE 67 SNAPSHOT OF BECTON DICKINSON
TABLE 68  SNAPSHOT OF LUMINEX CORPORATION
TABLE 69 SNAPSHOT OF AMNISCORPORATION
TABLE 70 SNAPSHOT OF PARTEC GMBH
TABLE 71 SNAPSHOT OF EBIOSCIENCE, INC.
TABLE 72 SNAPSHOT OF  MORPHOSYS AG


 
LIST OF FIGURES:

FIG. 1 FLOW CYTOMETRY MARKET DEFINITION
FIG. 2 TOP FACTORS IMPACTING FLOW CYTOMETRY MARKET(2013-2020)
FIG. 3 TOP THREE WINNING STRATEGIES OF FLOW CYTOMETRY MARKET (2010-2013)
FIG. 4 TOP INVESTMENT MARKETS BY CLINICAL APPLICATION
FIG. 5 TOP INVESTMENT MARKETS BY RESEARCH APPLICATION
FIG. 6 TOP INVESTMENT MARKETS BY END-USERS
FIG. 7 PORTER’S FIVE FORCE ANALYSIS
FIG. 8 TYPES OF PLATFORM
FIG. 9 NUMBER OF TRANSPLANTS PERFORMED IN THE UNITED STATES (2012)
FIG. 10 ESTIMATED NEW CASES OF LEUKEMIA, LYMPHOMA, MYELOMA (2013)
FIG. 11 ESTIMATED NEW CASES AS PER TYPES OF LEUKEMIA (2013)
FIG. 12 ESTIMATED NEW CASES AND DEATHS IN U.S.  (2012)
FIG. 13 TOP TEN COUNTRIES IN CANCER POPULATION (PER 1, 00,000 PEOPLE) 2011
FIG. 14 POPULATION LIVING WITH HIV/AIDS (TOP TEN COUNTRIES) 2012
FIG. 15 ESTIMATED NUMBER OF NEW CANCER CASES AND DEATHS, BY SITES U.S (2013)
FIG. 16 SWOT ANALYSIS OF ADVANCED ANALYTICAL TECHNOLOGIES, INC (AATI)
FIG. 17 FINANCIAL REVENUES OF MERCK MILLIPORE SALES BY BUSINESS UNIT (2012)
FIG. 18 FINANCIAL REVENUES OF MERCK MILLIPORE BY GEOGRAPHIC AREAS (2012)
FIG. 19 SWOT ANALYSIS OF MERCK MILLIPORE
FIG. 20 FINANCIAL REVENUES BY END MARKETS (2012)
FIG. 21 FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2012)
FIG. 22 SWOT ANALYSIS OF LIFE TECHNOLOGIES CORPORATION
FIG. 23 SWOT ANALYSIS OF BECKMAN COULTER, INC
FIG. 24 FINANCIAL REVENUES OF BECTON, DICKINSON & CO. BY GEOGRAPHIC AREAS (2012)
FIG. 25 FINANCIAL REVENUES OF BECTON, DICKINSON & CO. BY BUSINESS UNITS (2012)
FIG. 26 SWOT ANALYSIS OF BECTON, DICKINSON & CO
FIG. 27 REVENUE BY SALES TO CUSTOMERS (2012)
FIG. 28 SWOT ANALYSIS OF LUMINEX CORPORATION
FIG. 29 SWOT ANALYSIS OF AMNIS CORPORATION
FIG. 30 SWOT ANALYSIS OF PARTEC GMBH
FIG. 31 SWOT ANALYSIS OF EBIOSCIENCE, INC
FIG. 32 FINANCIAL REVENUES OF MORPHOSYS AG BY BUSINESS UNITS (2012)
FIG. 33 FINANCIAL REVENUES OF  MORPHOSYS AG BY GEOGRAPHIC AREAS (2012)
FIG. 34 SWOT ANALYSIS OF MORPHOSYS AG

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
Flow cytometer is a high throughput measurement technology, which does large variety of cell level measurements from cell counting to quantification of proteins. Comparing to the last decade the speed and accuracy of this technology has increased. Previously only few samples could be analyzed in a certain period of time but nowadays many samples can be analyzed simultaneously using this technology. Complex analysis offered by flow cytometry allows analysis of various cell signaling and phenotypes of stem cells. This technology has the capabilities to conjugate antibodies to bio molecules, dyes, linkers, drugs, etc. Flow cytometer is also capable of measuring six markers and can produce 3 million data points from single patient. Cell based flow cytometry is commonly used for measurement and diagnosis in blood cancer. This market research report is an effort to provide the clear picture of the state of the market and sub markets over the next seven years. The report provides micro level analysis of the factors affecting the market, key market trends and industry drives and challenges for the better understanding of the market structure. The presentation of the market dynamics, competitive scenario and developments will enable marketers to aptly design their growth strategies and have competitive edge. Moreover, assessment of the top investment pockets and winning strategies will help in channelizing their investments in the right directions to garner better proceeds.
SIMILAR MARKET STUDIES

Published Reports

Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process. These medicines are capable of restoring the functionality of cells and tissues. These medicines find applicability in wide range of degenerative disorders including dermatology, neurodegenerative diseases, cardiovascular and orthopedic applications. Researchers are engaged in developing technologies based on biologics, genes, somatic as well as stem cells.
30 Jun 2014 | Price: $4515(SU) | View Details >>

Synthetic biology is a novel field that finds its origin at the intersection of biology and engineering. It involves designing and construction of biological systems or devices that can be applied in varied domains to get specified results. Its a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system. Global synthetic biology market was valued at $3.0 billion in 2013 and it is estimated to reach $38.7 billion by 2020, growing at a CAGR of 44.2% during the forecast period.
27 May 2014 | Price: $4515(SU) | View Details >>

The bioinformatics market is expected to grow to $12.86 billion by 2020 with a CAGR of 21.2% during 2014-2020. Bioinformatics is an interdisciplinary field that is used in the development and storage of data, thus helping in the analysis, organization and retrieval of the biological data. Bioinformatics has various applications and thus forms part of almost all the fields in biology. Bioinformatics form a part of agriculture, animal breeding, molecular medicine, preventive medicine, etc. The major factors driving the bioinformatics market is the need for integrated data, rising demand for drug development and discovery, the increasing focus in genomics & proteomics and the favorable government initiatives.
28 May 2014 | Price: $4515(SU) | View Details >>

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment. Companion diagnostics market is still nascent, and it is projected to reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013, growing at a CAGR of 20% during 2014 to 2020. The global companion diagnostic market is segmented based on indication, technology and geography (North America, Europe, Asia Pacific and LAMEA). Geographically, LAMEA is the fastest growing region. The key drivers for this market are the increase in the discovery of biomarkers and co-development of drug and corresponding diagnostic. However, cost associated with developing drugs could impede the growth of this market.
10 Jun 2014 | Price: $4515(SU) | View Details >>

Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells. Global stem cell market is dominating the healthcare industry with its reliable and cost effective method of treatment with fewer side effects. Current market for cord blood therapeutics accounts for $6.5 billion, which is expected to grow at 33.4% CAGR from 2013-2020. Other segments of this market include - Adult stem cell and embryonic stem cells. Government authorities are supporting the research and clinical trials of cord blood stem cell, which is currently increasing the interest of healthcare companies to invest in research and commercialization of cord blood stem cell therapies.
21 Jan 2014 | Price: $4515(SU) | View Details >>

Upcoming Reports

STDs are sexually transmitted infections generally known as sexually transmitted diseases (STD) or venereal diseases. These are illness transmitted between humans as a result of sexual behavior. A variety of methods have been employed for the identification and assessment of these diseases based on their types. Some of the commonly known types of STDs are Gonorrhea, Syphilis and HIV AIDS. The objective of this report is to provide an in-depth understanding of the market scenario of diagnostic testing of STDs.
Price: $4515 | Pre Book Price: $4515 | View Details >>

Tissue engineering is the combination of biology medicine and engineering to create products that would improve or replace biological functions or organs. More than a decade ago, the industry introduced the first FDA approved tissue-engineering product, which was a skin substitute product. These products provide natural regeneration of tissues or cells, and hence are highly effective. The medical biotechnology industry was estimated to be $160 billion in 2012.The major drivers in this industry are chronic wound and orthopedic application segment.
Price: $4515 | Pre Book Price: $4515 | View Details >>

Cardiac Biomarkers are protein substances released into the blood stream from damaged heart muscles. These are the biological parameters that are used to detect the presence of cardiovascular diseases. According to World Health Organization, in 2008, 17.3 million people died due to cardiovascular diseases and it is expected to reach 23.3 million by 2030. This increase in cardiovascular diseases across the globe widens the global cardiac biomarkers market. With the prevalence of these cardiovascular diseases, demand for cardiac biomarkers would increase in future for early diagnosis and disease management.
Price: $4515 | Pre Book Price: $4515 | View Details >>

The endocrine system comprises of the endocrine glands such as the pituitary, thyroid, pancreas, adrenal, etc. These glands secrete hormones that regulate the bodys metabolism, growth, sexual development and function. Endocrine tests help in assessing the normal functioning of the endocrine gland by checking the hormone levels. The tests detect the imbalance in hormonal levels. The various tests, their advantages and uses are described in the report. The endocrine testing market is driven by the increasing incidences of endocrine disorders such as diabetes, thyroid disorders, infertility, etc.
Price: $4515 | Pre Book Price: $4515 | View Details >>

C-Reactive Protein Tests are blood tests that measure the levels of C-Reactive Protein. C-reactive protein is a protein that is produced by the liver and its level increase when there is inflammation in the body. C-reactive tests identify and keep track of infections and diseases that cause inflammation such as certain types of cancers, cardiovascular diseases, arthritis, etc. According to the WHO, an estimated 17.3 million people died of cardiovascular diseases in 2008 alone. C-reactive protein tests estimate the risks of a person suffering from heart attacks or strokes. The main drivers for this market are the increasing incidences of cardiovascular diseases, and the sheer volume of tests required. Lack of public awareness would be a challenge to growth of this market.
Price: $4515 | Pre Book Price: $4515 | View Details >>
First time Buyer ?
Check offer and
discount on this report


Get Discount

NEED MORE INFORMATION?
Call
+1 617 674 4143


Purchase Enquiry

PURCHASE OPTIONS

Single User
By obtaining a Single User License, you and your organization concur that only an individual uses this report either electronically or online. The right to use or stockpiling of the report should be confined only to one authorized computer. User will have authorization to print one duplicate of the report for individual use, yet may not be replicated for circulation. Additional copies for this report may also be order at discounted price for use by addition readers/users.
$4515

Multi User 
Multi-User license permits you to access the report from eight authorized computers. It does not permit you to display it on your company website and permits you to only print 5 copies of the report that shall not be reproduced for circulation.
$7515

Corporate  
With corporate use license, the complete or part of the content of the report can be shared or made available to other persons, other divisions and subsidiaries of same company. However, reproduction or redistribution of the report in is prohibited without the prior permission of Allied Market Research. The publisher will, in turn, regard the privacy of the purchaser and will keep it confidential. Upon buying single or multi-user license, buyer must provide the names and email ids of the authorized users of this report.
$10515


Not Interested in buying complete report?
To check the cost of chapters

WHY ALLIED MARKET RESEARCH?
INFALLIBLE METHODOLOGY
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader






Top